Non-specific biomolecular adsorption (NSBA)

Non-specific biomolecular adsorption is the spontaneous and uncontrolled accumulation of proteins, lipids, and other biological molecules onto the surface of an implanted medical device or biosensor (Wilson et al., 2011, Chemical Reviews). This process is primarily driven by the Vroman effect, where smaller, more abundant proteins are gradually replaced by larger proteins with higher surface affinity (Vroman, 1962, Nature). The resulting protein layer, or corona, mediates subsequent cellular interactions, serving as the critical first step in the foreign body response (Anderson et al., 2008, Seminars in Immunology). This biological cascade often leads to chronic inflammation, fibrous encapsulation, and eventual device failure or loss of sensitivity (Ratner, 2011, Journal of Controlled Release). In blood-contacting applications, this adsorption can trigger the coagulation cascade, leading to life-threatening thrombosis (Gorbet & Sefton, 2004, Biomaterials). While not a classical molecular target like a receptor, it is the primary focus of anti-fouling strategies in biomedical engineering. Therapeutic interventions involve surface modifications using stealth materials such as polyethylene glycol (PEG) or zwitterionic polymers that create a physical or energetic barrier to prevent biomolecules from reaching the underlying substrate (Lowe et al., 2015, Polymer Chemistry).

Other names

BiofoulingProtein foulingNon-specific protein bindingSurface-induced protein adsorptionVroman effect

Steric repulsion and hydration layer formation to inhibit protein-surface interactions